Looking for Retail and Wholesale Stocks? The Zacks Rank Can Help You Find Winners

In this article:

It doesn't matter if you're a growth, value, income, or momentum-focused investor -- building a successful investment portfolio takes skill, research, and a little bit of luck.

Should You Buy #1 (Strong Buy)-Ranked American Eagle Outfitters (AEO) for Your Portfolio?

American Eagle Outfitters was upgraded to the Zacks Rank #1 list on January 23, 2024. The Zacks Rank is a unique stock-rating model that helps you take advantage of earnings estimate revision trends and provides a way to get into stocks highly sought after by institutional investors.

Based in Pittsburgh, PA, American Eagle Outfitters Inc. is a specialty retailer of casual apparel, accessories and footwear for men and women aged 15–25 years. American Eagle, along with its subsidiaries, engages in the designing and marketing of casual clothing. The company’s assortment includes jeans, cargo pants, graphic T-shirts as well as a range of accessories, outerwear and footwear.

For fiscal 2025, seven analysts revised their earnings estimate upwards in the last 60 days, and the Zacks Consensus Estimate has increased $0.20 to $1.71 per share. AEO boasts an average earnings surprise of 22.7%.

Earnings are forecasted to see growth of 12.5% for the current fiscal year, and sales are expected to increase 3.3%.

AEO has been moving higher over the past four weeks as well, up 8.4% compared to the S&P 500's gain of 1.7%.

Bottom Line

With a #1 (Strong Buy) ranking, positive trend in earnings estimate revisions, and strong market momentum, American Eagle Outfitters could be just the stock to help your portfolio generate returns that could fund your retirement, your kids' college tuition, or your short- and long-term savings goals.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

American Eagle Outfitters, Inc. (AEO) : Free Stock Analysis Report

Zacks Investment Research

Advertisement